Clinical trial reportMultiple sclerosis and related disordersPublished
Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Clinical trial report
- Venue
- Multiple sclerosis and related disorders
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Sclerosis, Relapsing-Remitting; Benzylidene Compounds; Thiazoles; Magnetic Resonance Imaging; Treatment Outcome; Double-Blind Method; Adult; Middle Aged; Female; Male; Young Adult
- PubMed ID
- 42561748
- Added to directory
- Source checked